Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease

Launched by CENTRE HOSPITALIER INTERCOMMUNAL CRETEIL · May 22, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how non-invasive ventilation (NIV) is used to help people with bronchial dilatation disease, also known as bronchiectasis. The study is not giving any new treatments; instead, it's gathering information from medical records to better understand the people who receive long-term NIV. Researchers want to learn about the characteristics of these patients, why they started using NIV, and how it is adjusted over time.

To be eligible for this study, participants must be over 18 years old and have a confirmed diagnosis of bronchiectatic disease, which is a condition that affects the airways in the lungs, based on imaging tests. People with cystic fibrosis, certain types of lung diseases like COPD or asthma, or those who do not wish to participate will not be included. For those who do take part, their existing medical records will be reviewed to gather the necessary information. This study is currently recruiting participants of all genders aged 18 and older.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18 years
• • Predominant diagnosis of bronchiectatic disease, excluding cystic fibrosis, confirmed by computed tomography
• • Introduction of long-term NIV at a given point in the patient's care
• Exclusion Criteria:
• • Patient's opposition to participating in this study
• • Cystic fibrosis
• • Predominant diagnosis of COPD or asthma, traction bronchiectasis, bronchiectasis resulting from focal endobronchial lesion, sarcoidosis or active allergic bronchopulmonary aspergillosis.